Inovio Pharmaceuticals, Inc. (INO) announced Tuesday an accelerated timeline for developing its DNA vaccine INO-4800 to address COVID-19, the respiratory infection the World Health Organization (WHO) has designated a Public Health Emergency of International Concern of the highest level.
from RTT - Biotech https://ift.tt/3anpekr
via IFTTT
No comments:
Post a Comment